会议专题

Restoration of microRNA-18a results in an improvement of Imatinib therapy on secondary imatinib-resistance metastatic melanoma

Imatinib generated remarkable clinical response in melanomas harboring c-kit mutation.However,melanoma resistance to imatinib develops rather quickly in most of the patients.

Yan Kong Long Liang Xiaowei Xu Lu Si Lili Mao Bixia Tang Jie Dai Zhihong Chi Xinan Sheng Chuanliang Cui Siming Li Bin Lian Jun Guo

Department of Renal cancer and Melanoma, Peking University School of Oncology, Beijing Cancer Hospit Department of Pathology and Laboratory Medicine, Abramson Cancer Center of the University of Pennsyl

国内会议

第十六届全国临床肿瘤学大会暨2013年CSCO学术年会

厦门

英文

123-124

2013-09-25(万方平台首次上网日期,不代表论文的发表时间)